Company Directory / research
PrivateFor profitresearchEindhoven, Netherlands
AmbAgon Therapeutics
AmbAgon Therapeutics is a developer of cancer molecule therapeutics.
- Founded
- 2020 6 years ago
- Staff
- 11-50 band, as listed
- Followers
- - on LinkedIn
- Funding
- $148M as listed, currency not stated
Set against six million companies
Size
11-50 people: larger than 33% of companies with a size listed
Age
6 years old.
Reach
Website ranked #4,710,704 in the world for traffic, about 2k visits a month.
What it does
BiotechnologyMedicalProduct Research
Funding, as listed
$148M currency not stated
- Rounds3
- LatestSeries unknown, May 2022
- Investors8, 1 leading
What the source datasets report. We have not watched these rounds ourselves.
Every detail we hold
Everything the source datasets list about AmbAgon Therapeutics, field by field. Contact details are held but never shown.
The company
- Name
- AmbAgon Therapeutics
- Type
- For profit
- Status
- Private
- Founded
- 2020
- Founders
- Christian Ottmann, Lucas Brunsveld, Michelle Arkin
- Industry
- research
- Categories
- Biotechnology, Medical, Product Research
Where
- City
- Eindhoven
- Country
- Netherlands
- Markets
- San Francisco Bay Area, West Coast, Western US
Size and reach
- Staff band
- 11-50
- Web traffic rank
- #4,710,704
- Monthly web visits
- 1,959
Funding, as listed
- Total
- 147,999,996 (currency not stated)
- Rounds
- 3
- Latest round
- Series unknown
- Latest round date
- May 2022
- Investors
- 8
- Lead investors
- 1
- Listing status
- private
About this record
- Sources
- Crunchbase
- Last imported
- Sept 2026
Companies like it
research in Netherlands.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 174,966 companies in Netherlands and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.